Correlation Between Cingulate and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on Cingulate and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Dermata Therapeutics.
Diversification Opportunities for Cingulate and Dermata Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cingulate and Dermata is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Cingulate i.e., Cingulate and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate and Dermata Therapeutics
Given the investment horizon of 90 days Cingulate is expected to generate 131.56 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, Cingulate is 7.45 times less risky than Dermata Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 6.35 in Dermata Therapeutics Warrant on November 2, 2024 and sell it today you would lose (3.38) from holding Dermata Therapeutics Warrant or give up 53.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 56.48% |
| Values | Daily Returns |
Cingulate vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
| Cingulate |
| Dermata Therapeutics |
Cingulate and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Dermata Therapeutics
The main advantage of trading using opposite Cingulate and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |